A5033440968- Cardiac Structural Anomalies and Repair
- Mechanical Circulatory Support Devices
- Cardiac Arrest and Resuscitation
- Heart Failure Treatment and Management
- Cardiovascular and exercise physiology
- Cardiovascular Function and Risk Factors
- Intensive Care Unit Cognitive Disorders
- Transplantation: Methods and Outcomes
- Cardiac Health and Mental Health
- Angiogenesis and VEGF in Cancer
- Cardiovascular Health and Disease Prevention
- Inflammatory Biomarkers in Disease Prognosis
- Cardiac, Anesthesia and Surgical Outcomes
- Viral Infections and Immunology Research
- Chemotherapy-induced cardiotoxicity and mitigation
- Heart Rate Variability and Autonomic Control
- Eosinophilic Disorders and Syndromes
- Family and Patient Care in Intensive Care Units
- Hemodynamic Monitoring and Therapy
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Cardiac pacing and defibrillation studies
- Coronary Artery Anomalies
- Frailty in Older Adults
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
NIMTS Hospital
2022-2025
National and Kapodistrian University of Athens
2018-2025
Alexandra Hospital
2024-2025
Evangelismos Hospital
2018-2024
Institute of Cardiology
2024
401 General Military Hospital of Athens
2023-2024
Onassis Cardiac Surgery Center
2023
Agios Pavlos General Hospital
2019
Vascular endothelial dysfunction is an underlying pathophysiological feature of chronic heart failure (CHF). Endothelial progenitor cells (EPCs) are also impaired. The purpose the study was to assess effect a cardiac rehabilitation (CR) program on increase EPCs at rest and acute response after maximal exercise in patients with CHF investigate whether there were differences between two training protocols NYHA II III classes. Forty-four stable enrolled 36-session CR randomized one protocol;...
Cardiovascular disease is commonly accompanied by renal dysfunction. Multimorbidity in hospitalized patients impacts unfavorably on prognosis and hospital stay. We aimed to illustrate the contemporary burden of cardiorenal morbidity across inpatient cardiology care Greece.
Concerns about the impact of new donor heart allocation system on posttransplant outcomes have emerged after its implementation. We sought to evaluate characteristics and left ventricular assist device (LVAD) recipients transplanted before implantation policy October 18, 2018.Data bridge transplantation adult patients with LVAD between January 2015 2021, durable as a (BTT), was queried from United Network Organ Sharing (UNOS) registry. The main were 30-day all-cause mortality, fatal graft...
Heart failure with reduced ejection fraction (HFrEF) is a complex clinical syndrome significant morbidity and mortality seems to be responsible for approximately 50% of heart cases hospitalizations worldwide. First-line treatments patients HFrEF, according the ESC AHA guidelines, include β-blockers, angiotensin receptor/neprilysin inhibitors, sodium-glucose cotransporter 2 mineralocorticoid receptor antagonists. This quadruple therapy should initiated during hospital stay uptitrated maximum...